Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.

Nakamura Y, Ratain MJ, Cox NJ, McLeod HL, Kroetz DL, Flockhart DA
J Natl Cancer Inst. 2012 104 (16): 1264; author reply 1266-8

PMID: 22851270 · DOI:10.1093/jnci/djs304

MeSH Terms (12)

Antineoplastic Agents, Hormonal Breast Neoplasms Cytochrome P-450 CYP2D6 Female Glucuronosyltransferase Humans Neoplasm Recurrence, Local Nitriles Polymorphism, Single Nucleotide Postmenopause Tamoxifen Triazoles

Connections (1)

This publication is referenced by other Labnodes entities: